Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
Clinical trial NCT05782127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05782127
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2025-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.